What Researchers Did
Researchers followed up on 26 patients who had been treated with hyperbaric oxygen therapy as part of their care for osteonecrosis of the jaw after radiation, and checked the current status of 20 of them.
What They Found
In this clinical follow-up study of 20 patients treated with hyperbaric oxygen therapy for postradiation osteonecrosis of the jaw, 60% (12 of 20) still had the condition resolved at long-term follow-up, and 20% (5 of 20) had chronic persisting disease. Another 10% (2 of 20) improved in clinical stage, going from symptomatic to unresolved or resolved. Two of 20 patients had a recurrence, one linked to surgical treatment and one that appeared related to periodontal disease. The authors reported that patients remain at risk up to 231 months after cancer treatment, and probably indefinitely.
What This Means for Canadian Patients
For people with osteonecrosis of the jaw after head and neck radiation, this study suggests the condition can appear years after treatment and may come back, although second episodes were uncommon here. The authors also reported that chronic, non-progressive disease can stay stable without extensive intervention, including combined hyperbaric oxygen therapy and surgery. The study had no comparison group, so it cannot show whether hyperbaric oxygen therapy caused the outcomes seen.
Canadian Relevance
The study has Canadian authors, so it has a direct Canadian connection.
Study Limitations
Only 20 of the 26 patients were evaluated, all had received hyperbaric oxygen therapy, and there was no comparison group, so the results cannot show what the therapy itself contributed.